Skip to content
Recall Observatory FDA recall evidence

Drug product

Xolair (omalizumab injection), 150 mg/ml, 1 auto-injector, Rx only, Genentech, Inc, South San Francisco, CA 9408, NDC: 50242-215-55.

D-0571-2025

July 30, 2025

Class II

Product summary

Firm
Cardinal Health Inc.
Event
Event 97360
Status
Ongoing
Classification
Class II
Quantity
6 units
Official record key
drug-enforcement:D-0571-2025

Official wording

Reason: CGMP Deviations - Product was exposed to temperatures outside the product's labeled storage requirements.

Code information: Lot: 3617756, Expires: 12/31/2025.

Distribution pattern: Nationwide Within the U.S.

Derived failure modes

  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    CGMP Deviations